Nektar Presents Positive Preclinical Data On Oral, Peripherally-Acting Kappa Agonist Molecules At 2014 American Academy Of Pain Management Meeting
September 19, 2014 at 09:01 AM EDT
Nektar Therapeutics (NASDAQ: NKTR) today announced results from preclinical studies characterizing the analgesic profiles of a series of ...